IRIS
GRANDALIANO, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.332
EU - Europa 4.810
AS - Asia 2.238
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 8
SA - Sud America 7
Totale 12.410
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.311
IE - Irlanda 1.701
CN - Cina 1.699
UA - Ucraina 1.280
SE - Svezia 723
IT - Italia 301
IN - India 242
FI - Finlandia 232
FR - Francia 212
TR - Turchia 157
DE - Germania 136
GB - Regno Unito 110
SG - Singapore 90
CZ - Repubblica Ceca 40
BE - Belgio 35
KR - Corea 21
CA - Canada 20
RU - Federazione Russa 16
EU - Europa 14
PK - Pakistan 11
NL - Olanda 10
ES - Italia 9
AU - Australia 7
CL - Cile 5
JP - Giappone 4
IQ - Iraq 3
SA - Arabia Saudita 3
BR - Brasile 2
IR - Iran 2
MY - Malesia 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
EE - Estonia 1
GR - Grecia 1
HK - Hong Kong 1
ID - Indonesia 1
KH - Cambogia 1
LU - Lussemburgo 1
MX - Messico 1
NZ - Nuova Zelanda 1
PH - Filippine 1
Totale 12.410
Salva come PNG Salva come JPEG
Città #
Dublin 1.701
Chandler 1.022
Jacksonville 910
Dearborn 532
Nyköping 484
Nanjing 463
Wilmington 214
Ashburn 204
Beijing 203
Nanchang 191
Princeton 188
San Mateo 181
New York 126
Shenyang 120
Boardman 111
Ann Arbor 96
Hebei 83
Des Moines 76
Helsinki 67
Jiaxing 67
Kunming 65
Changsha 64
Tianjin 60
Singapore 53
Jinan 48
Pune 40
Woodbridge 40
Hangzhou 39
Ningbo 36
Brno 35
Zhengzhou 33
Brussels 32
Foggia 31
Taizhou 28
Guangzhou 27
Shanghai 25
Hilden 24
Seattle 24
Lanzhou 20
Munich 20
Auburn Hills 18
Los Angeles 17
Augusta 15
Bari 15
Orange 15
Changchun 14
Rome 14
Norwalk 12
Falls Church 11
Lahore 11
Toronto 11
Wuhan 11
Fuzhou 10
Leawood 10
Washington 10
Saint Petersburg 9
Milan 7
San Francisco 7
Bologna 6
Haikou 6
Hefei 6
Jinhua 5
London 5
Paris 5
Redwood City 5
Bisceglie 4
Borås 4
Clifton 4
Kolkata 4
Murcia 4
Olomouc 4
Palese 4
Rockville 4
Shenzhen 4
Stevenage 4
Amsterdam 3
Avigliano 3
Baghdad 3
Dongyang 3
El Segundo 3
Florence 3
Genova 3
Kocaeli 3
Melbourne 3
Mountain View 3
Noicattaro 3
Philadelphia 3
Redmond 3
Santa Clara 3
Shaoxing 3
Xuzhou 3
Bangalore 2
Bitetto 2
Bitonto 2
Brescia 2
Buffalo 2
Canosa Di Puglia 2
Chengdu 2
Chicago 2
Crevalcore 2
Totale 8.144
Salva come PNG Salva come JPEG
Nome #
Metodo per il dosaggio del fattore di crescita epidermico (EGF) e del peptide-1 chemiotattico dei monociti umani (MCP-1) in un campione biologico e relativo kit diagnostico 198
Post-void residual urinary volume is an independent predictor of biopsy results in men at risk for prostate cancer 132
La riduzione dei livelli sierici di BAFF e APRIL si associa alla negativizzazione degli anticorpi anti-recettore della fosfolipasi A2 (PLA2R) nei pazienti affetti da glomerulonefrite membranosa idiopatica (iMN) 120
The role of alpha-smooth muscle actin and platelet-derived growth factor-beta receptor in the progression of renal damage in human IgA nephropathy. 114
The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. 112
Activated coagulation factor X: a novel mitogenic stimulus for human mesangial cells 111
Progression of renal damage in human glomerulonephritides: is there sleight of hand in winning the game? 106
Prospective randomized controlled multicenter trial on steroids plus ramipril in proteinuric IgA nephropathy. 104
High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. 104
Sirolimus interferes with iron homeostasis in renal transplant recipients 101
“Urinary excretion and renal expression of monocyte chemotactive peptide-1 (MCP-1) and epidermal growth factor expression (EGF) in children with reflux and obstructive nephropathies 101
ADAMTS13 MUTATIONS AND POLYMORPHISMS IN CONGENITAL THROMBOTIC THROMBOCYTOPENIC PURPURA. 99
PROSTATE CANCER IS CHARACTERIZED BY A DYSREGULATION OF THE IMMUNE RESPONSE 99
Atti 52° Congresso Nazionale della Società Italiana di Nefrologia. Genova, 21-24 Settembre, 2011 98
“Urinary epidermal growth factor (EGF) concentration in children affected by severe obstructive and reflux uropathy”. 97
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 97
Additive effect of cyclosporine and low density lipoproteins on transforming growth factor-beta 1 and monocyte chemotactic protein-1 expression in human mesangial cells. 96
ESCREZIONE URINARIA DI MONOCYTE CHEMOTACTIC PEPTIDE-1 ED EPIDERMAL GROWTH FACTOR NELL’UROPATIA OSTRUTTIVA IN ETÀ PEDIATRICA 96
Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes 96
[Cardiovascular risk in polycystic kidney disease] 96
Espressione renale di epidermal growth factor (EGF) e monocyte chemotactic peptide-1 (MCP-1) in bambini affetti da stenosi del giunto pielo-ureterale. 92
“Espressione renale della proteina chemotattica per i monociti (MCP-1) e del fattore di crescita epidermico (EGF) in bambini affetti da stenosi del giunto pielo-ureterale (SGPU).” 92
A novel biologic activity of thrombin: stimulation of monocyte chemotactic protein production. 91
Creazione di un database multimediale per la gestione della telepatologia statica e della telemorfometria nella immunopatologia renale 89
Renal cortical complement C3 gene expression in IgA nephropathy 89
Fibrin down-regulates LPS- and PMA- induced tissue factor expression by blood mononuclear cells. 88
Monocyte recruitment in cryoglobulinemic membranoproliferative glomerulonephritis: a pathogenetic role for monocyte chemotactic peptide-1. 88
Epidemal growth factor and monocyte chemotactic protein-1 renal expression and urinary levels in pediatric ureteropelvic junction obstruction 87
Proteomic profile of plasma proteins eluted from Coupled Plasma Filtration-Adsorption (CPFA) sorbent resin cartridges in a swine model of sepsis 87
“Epidermal growth factor (EGF) and monocyte chemotactic peptide-1 (MCP-1) renal expression in children affected by ureteropelvic junction obstruction” 86
La Fetuina A è ridotta nel siero e nelle urine dei pazienti affetti da nefro-urolitiasi ricorrente 86
Sirolimus and angiotensin-converting enzyme inhibitors together induce tongue oedema in renal transplant recipients 85
Espressione renale e livelli urinari di fattore di crescita epidermico ed proteina chemotattica dei monociti-1 in bambini con stenosi del giunto pielo-ureterale 84
Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells 84
Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection 83
Incidence of anemia in sirolimus-treated renal transplant recipients: the importance of preserving renal function. 83
High pretransplant serum levels of CXCL9 are associated with increased risk of acute rejection and graft failure in kidney graft recipients. 83
Captopril enhances transforming growth factor (TGF)-beta1 expression in peripheral blood mononuclear cells: a mechanism independent from angiotensin converting enzyme inhibition? A study in cyclosporine-treated kidney-transplanted patients. 82
Addition of sirolimus to cyclosporine delays the recovery from delayed graft function but does not affect 1-year graft function. 82
Altered urinary excretion of aquaporin 2 in IgA nephropathy. 82
Clinical and therapeutic aspects of diabetic nephropathy 82
Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy. 81
Cardiovascular risk and renal transplantation 81
Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation 81
Proteomic profile of CD24+ CD133+ renal multipotent progenitors (RMP) 81
Tissue factor, plasminogen activator inhibitor-1, and thrombin receptor expression in human crescentic glomerulonephritis 80
Thrombin: a novel renal growth factor. 79
Placental imbalance of vasoactive factors does not affect pregnancy outcome in patients treated with cyclosporine A after transplant 79
INCREASE OF PROLIFERATING RENAL PROGENITOR CELLS IN ACUTE TUBULAR NECROSIS UNDERLYING DELAYED GRAFT FUNCTION IN KIDNEY TRANSPLANTATION 79
Angiotensin Inhibition Mycophenolate mophetil IgA Nephropathy study investigators. One-year angiotensin-converting enzyme inhibition plus mycophenolate mofetil immunosuppression in the course of early IgA nephropathy: a multicenter, randomised, controlled study. 79
Pentraxin 3: A novel biomarker for predicting progression from prostatic inflammation to prostate cancer 79
Acute renal failure in critically ill patients. 78
Increased placental expression of tissue factor is associated with abnormal uterine and umbilical Doppler waveforms in severe preeclampsia with fetal growth restriction 78
Kaposi's sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression 77
Anti-Fibrotic Effect of Mycophenolic Acid-Induced Neutral Endopeptidase. 77
A study on glucose metabolism in a small cohort of children and adolescents with kidney transplant. 77
A single-center cohort study to define the role of pretransplant biopsy score in the long-term outcome of kidney transplantation 77
Activation of PLC and PI 3 kinase by PDGF receptor alpha is not sufficient for mitogenesis and migration in mesangial cells. 76
Children with obstructive uropathy showed renal overexpression of plasminogen activator inhibitor-1 unrelated to renal expression of angiotensinogen 75
Espressione renale di PAI-1 (Plasminogen activator inhibitor-1) ed angiotensinogeno (AGT) in bambini con nefropatia ostruttiva (NO). 75
Rapamycin treatment for benign multicystic peritoneal mesothelioma: A rare disease with a difficult management 75
Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer. 74
Association of urinary laminin G-like 3 and free K light chains with disease activity and histological injury in IgA nephropathy. 74
mTOR inhibitors effects on regulatory T cells and on dendritic cells 74
MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy 73
A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD) 73
Rapamycin Inhibits PAI-1 Expression and Reduces Interstitial Fibrosis and Glomerulosclerosis in Chronic Allograft Nephropathy 72
Addition of sirolimus to cyclosporine delays the recovery from delayed graft function but does not affect 1-year graft function 72
Platelet-leukocyte interactions in hemodialysis patients: culprit or bystander? 72
Acute kidney injury in the elderly population. 72
Exposure to low- vs. iso-osmolar contrast agents induces NADPH-dependent Reactive Oxygen Species (ROS) genereration in a cellular model of renal injur 72
Cytokines and bioincompatibility 71
Trapianto di rene doppio. Analisi retrospettiva dei dati relativi alla popolazione dei pazienti portatori di trapianto renale doppio in ambito AIRT 71
Anaemia management in non-dialysis chronic kidney disease (CKD) patients: A multicentre prospective study in renal clinics 71
Cyclosporin exposure correlates with 1 year graft function and histological damage in renal transplanted patients 70
Angiotensin IV and renal diseases. 70
Inflammation and carnitine in hemodialysis patients. 70
Thrombin regulates expression of monocyte chemoattractant protein-1 in vascular smooth muscle cells. 69
Allograft nephrectomy: what is the best surgical technique? 69
Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation 69
“Monocyte chemotatic protein-1 and epidermal growth factor (EGF) expression and secretion in xanthogranulomatous pyelonephritis 68
Actions of platelet-derived growth factor isoforms in mesangial cells. 68
Treatment with rituximab in idiopathic membranous nephropathy 68
Ramipril inhibits in vitro human mesangial cell proliferation and platelet-derived growth factor expression. 67
PROTEOMIC PROFILE OF CD24+CD133+RENAL MULTIPOTENT PROGENITORS (RMP) 67
Clinical relevance of citokine production in hemodialysis. 66
Ischemia-reperfusion induces glomerular and tubular activation of pro-inflammatory and anti-apoptotic pathways: differential modulation by rapamycin. 66
BMP-2 INDUCES A PRO-FIBROTIC PHENOTYPE IN DULT RENAL PROGENITOR CELLS THROUGH Nox4 ACTIVATION. 66
Immunohistochemical characterization of glomerular and tubulointerstitial infiltrates in renal transplant patients with chronic allograft dysfunction. 65
The role of tubular cells in the progression of renal damage: guilty or innocent? 64
In vivo modulation of soluble "antagonistic" IL-6 receptor synthesis and release in ESRD. 64
Renal injury after low-or iso-osmolar contrast agent exposure:an in vitro study 64
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis 64
The role of hyperparathyroidism, erythropoietin therapy, and CMV infections in the failure of arteriovenous fistula in hemodialysis. 63
Vitamin E-modified filters modulate Jun N-terminal kinase activation in peripheral blood mononuclear cells. 63
Recidive della nefropatia di base e nefropatie “de novo” in pazienti portatori di trapianto renale 63
Rapamycin induces ILT3highILT4high dendritic cells promoting a new immunoregulatory pathway 63
Management and prevention of post-transplant malignancies in kidney transplant recipients 63
Management of Side Effects of Sirolimus Therapy. 62
“Renal expression of monocyte chemotatic protein-1 (MCP-1) and epidermal growth factor (EGF) in children with obstructive hydronephrosis 61
Totale 8.199
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.106
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.106
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.863 633 384 136 35 333 312 452 35 244 42 234 23
2020/20211.460 197 8 190 10 187 100 214 61 209 269 12 3
2021/2022963 171 3 39 15 63 16 17 76 123 112 35 293
2022/20234.137 375 200 243 247 221 353 37 297 1.976 18 66 104
2023/2024810 92 22 37 32 53 278 68 60 4 11 13 140
2024/2025146 146 0 0 0 0 0 0 0 0 0 0 0
Totale 12.660